Quick Comparison
| ALCAR | NAC | |
|---|---|---|
| Half-Life | 4-5 hours | 5.6 hours |
| Typical Dosage | Standard: 500-2000 mg daily in 1-2 doses. For cognitive support: 1000-2000 mg daily. For neuropathy: 1500-3000 mg daily. Take in the morning — may be mildly stimulating. | Standard: 600-1800 mg daily in 1-2 divided doses. Clinical (OCD/addiction): 1200-2400 mg daily. Take on an empty stomach for best absorption. Some practitioners combine with Vitamin C to enhance glutathione recycling. |
| Administration | Oral (capsules, powder). Well-absorbed on an empty stomach. | Oral (capsules, powder). Take on an empty stomach. Unpleasant sulfur taste in powder form. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
ALCAR
ALCAR crosses the blood-brain barrier via the organic cation transporter (OCTN2) more effectively than L-carnitine. In neurons, it is hydrolyzed by carnitine acetyltransferase to donate its acetyl group to coenzyme A, forming acetyl-CoA—which can then be used for acetylcholine synthesis via choline acetyltransferase, effectively providing raw material for the memory neurotransmitter. ALCAR also transports long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase system for beta-oxidation and ATP production. ALCAR activates nerve growth factor (NGF) signaling, possibly through modulation of NGF receptor (TrkA) expression or downstream MAPK/ERK pathways. It has antioxidant properties, reducing lipid peroxidation in mitochondrial membranes and scavenging free radicals. These mechanisms support cognitive function and neuroprotection.
NAC
NAC is deacetylated to cysteine, the rate-limiting substrate for glutathione synthesis via gamma-glutamylcysteine synthetase and glutathione synthetase. Glutathione (GSH) is the primary intracellular antioxidant in neurons, neutralizing reactive oxygen species and maintaining redox balance. NAC also activates the cystine-glutamate antiporter (System Xc-, composed of SLC7A11 and SLC3A2 subunits), which exchanges extracellular cystine for intracellular glutamate in a 1:1 ratio. This non-vesicular mechanism modulates extrasynaptic glutamate levels, reducing NMDA receptor overactivation and excitotoxicity. The glutamate-modulating effect explains NAC's promise in OCD (reducing corticostriatal glutamate hyperactivity), addiction (normalizing nucleus accumbens glutamate after drug exposure), and neurodegenerative conditions involving glutamate dysregulation.
Risks & Safety
ALCAR
Common
Nausea, fishy body odor, restlessness, gastrointestinal discomfort.
Serious
May increase agitation in Alzheimer's patients. TMAO production may be a cardiovascular concern with chronic high doses.
Rare
Seizures in susceptible individuals, increased thyroid activity.
NAC
Common
Nausea, vomiting, diarrhea, foul-smelling breath.
Serious
May interact with blood thinners and nitroglycerin. Concern that antioxidants may reduce efficacy of chemotherapy (theoretical).
Rare
Bronchospasm (in people with asthma), anaphylactic-like reactions.
Full Profiles
ALCAR →
Acetyl-L-Carnitine is an acetylated form of L-Carnitine that crosses the blood-brain barrier more effectively than regular L-Carnitine. In the brain, it donates its acetyl group for acetylcholine synthesis and supports mitochondrial fatty acid oxidation for energy. Used clinically for age-related cognitive decline, depression, and diabetic neuropathy.
NAC →
N-Acetyl Cysteine is a precursor to glutathione — the body's master antioxidant. In the brain, NAC provides potent neuroprotection against oxidative stress and also modulates glutamate signaling through the cystine-glutamate antiporter. It is used clinically for acetaminophen overdose and is studied for OCD, addiction, and neurodegenerative diseases.